Wild-type (senile) amyloidosis epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Wild-type (senile) amyloidosis}} | {{Wild-type (senile) amyloidosis}} | ||
{{CMG}} | {{CMG}}{{AE}}{{Sab}} | ||
==Overview== | ==Overview== |
Revision as of 17:59, 17 December 2019
Wild-type (senile) amyloidosis Microchapters |
Differentiating Wild-type (senile) amyloidosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Wild-type (senile) amyloidosis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Wild-type (senile) amyloidosis epidemiology and demographics |
FDA on Wild-type (senile) amyloidosis epidemiology and demographics |
CDC on Wild-type (senile) amyloidosis epidemiology and demographics |
Wild-type (senile) amyloidosis epidemiology and demographics in the news |
Blogs on Wild-type (senile) amyloidosis epidemiology and demographics |
Risk calculators and risk factors for Wild-type (senile) amyloidosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]
Overview
The incidence of amyloidosis is approximately 1.2 per 100,000 individuals per year worldwide. The actual incidence of wild-type (senile) amyloidosis in particular is unknown. he mortality rate of systemic amyloidosis is approximately 100 per 100,000 deaths in developed countries. Patients with wild-type (senile) amyloidosis are almost always elderly (65 years of age or older). There is no racial predilection to wild-type (senile) amyloidosis. Men are traditionally more commonly affected by wild-type (senile) amyloidosis than women.
Epidemiology and Demographics
Incidence
- The incidence of amyloidosis is approximately 1.2 per 100,000 individuals per year worldwide.[1]
- The actual incidence of wild-type (senile) amyloidosis in particular is unknown.
Prevalence
- The prevalence of wild-type (senile) amyloidosis has not been determined.
Mortality rate
- The mortality rate of systemic amyloidosis is approximately 100 per 100,000 deaths in developed countries.[2]
Age
- Patients with wild-type (senile) amyloidosis are almost always elderly (65 years of age or older).
Race
- There is no racial predilection to wild-type (senile) amyloidosis.
Gender
- Men are traditionally more commonly affected by wild-type (senile) amyloidosis than women.